WIC
TECH icon

Wilkins Investment Counsel’s Bio-Techne TECH Stock Holding History

Wilkins Investment Counsel’s Portfolio TECH Stock Details TECH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$13.4M Buy
189,412
+15,297
+9% +$826K 1.8% 24
2026
Q1 		$9.1M Buy
174,115
+70,847
+69% +$4.25M 1.3% 31
2025
Q4 		$6.07M Buy
103,268
+7,645
+8% +$465K 0.89% 41
2025
Q3 		$5.32M Buy
95,623
+9,010
+10% +$483K 0.75% 40
2025
Q2 		$4.46M Buy
86,613
+67,573
+355% +$3.4M 0.63% 45
2025
Q1 		$1.12M Sell
19,040
-4,950
-21% -$335K 0.16% 74
2024
Q4 		$1.73M Buy
23,990
+6,850
+40% +$503K 0.25% 65
2024
Q3 		$1.37M Buy
17,140
+650
+4% +$48.8K 0.19% 68
2024
Q2 		$1.18M Buy
16,490
+2,700
+20% +$199K 0.18% 68
2024
Q1 		$971K Sell
13,790
-1,050
-7% -$75.1K 0.14% 79
2023
Q4 		$1.15M Buy
14,840
+2,390
+19% +$157K 0.28% 51
2023
Q3 		$847K Buy
12,450
+3,125
+34% +$247K 0.23% 53
2023
Q2 		$761K Buy
9,325
+3,200
+52% +$257K 0.2% 53
2023
Q1 		$454K Buy
+6,125
New +$472K 0.12% 62

Other funds holding TECH

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
HI
HBK Investments Dallas, Texas $10.3B AUM 67.69% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Wilkins Investment Counsel's TECH Position: Q2 2026 in Review

Wilkins Investment Counsel increased its Bio-Techne (TECH) stake by 8.8% in Q2 2026, buying an estimated $826K and bringing the position to 189,412 shares worth $13.4M. The position accounts for 1.8% of the portfolio, ranked #24.

Wilkins Investment Counsel first reported a position in TECH in Q1 2023 and has held it in 14 quarters since. 596 funds tracked by Wall St. Rank hold TECH as of Q2 2026.

  • Wilkins Investment Counsel held 189,412 shares of Bio-Techne worth $13.4M as of Q2 2026.
  • Wilkins Investment Counsel bought 15,297 Bio-Techne shares in Q2 2026, an estimated $826K.
  • Bio-Techne made up 1.8% of Wilkins Investment Counsel's portfolio in Q2 2026, its #24 holding.
  • Wilkins Investment Counsel first reported a position in Bio-Techne in Q1 2023 and has held it in 14 quarters since.
  • 596 funds tracked by Wall St. Rank held Bio-Techne as of Q2 2026.

Based on Wilkins Investment Counsel's 13F filing for Q2 2026, filed 6 Aug 2026.